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136 Poster Presentation AbstractsDiscussion and Conclusions: Short-term treatment with microgravity caused
significantly changed of inflammatory cytolines production. The differential ef-
fects of simulated microgravity on TNF-a, IL-6, IL-1b, TLR-4 expression suggested
the different sensitivity to microgravity of signaling pathways regulating different
inflammatory cytokines in macrophages. Furthermore, microgravity impaired the
function of macrophage. The decreased inflammatory response of macrophages
and the damaged function caused by microgravity may contribute to the increased
susceptibility to infections of astronauts. LPS stimulates immune responses by
interacting with the membrane receptor TLR-4 to induce the generation of cyto-
kines. In the future work, the LPS-induced activation of signaling pathways down-
stream of TLR4, such as NF-kB and MAPK pathways will be tested.
http://dx.doi.org/10.1016/j.jot.2016.06.194Session: Disease & Treatment e Tumors
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Mfn2 INHIBITS THE PROLIFERATION OF OSTEOSARCOMA VIA
DOWNREGULATION OF plk1
Qingsong Tian a, Zhaohua Hu a, Heng Zhang a, Huadong Pei b, Xinhzhi Li a
aRenhe Hospital of Three Gorges University, China
bState Key Laboratory of Proteomics, Beijing Proteome Research Center, China
Objective: The tumor suppressor role of mitochondrial fusion gene 2 (Mfn2) have
been confirmed in many tumors. However, there are few reports about the mech-
anism of mfn2 on the development and progression of tumor. We will study the os-
teosarcoma in this research to reveal the correlation of Mfn2 and osteosarcoma. A
further demonstration of the potential mechanism between them will be included.
Methods: We collect the pathological specimens of osteosarcoma patients, and
then analysis the expression of mfn2 and its effect on the survival of patients
with osteosarcoma. A construction of lentiviral which overexpress the mfn2 is
needed. We would infect the osteosarcoma cell lines MG63 and U2OS with the len-
tiviral and then selected the positive cells with puromycin to obtain the stable
line. The exploration of the overexpression of mfn2 on the proliferation and the
apoptosis will be carried out. The purification of flag-mfn2 and a mass spectrom-
etry analysis are necessary to detect the interaction protein of mfn2. What’s
more, the interaction will be further identified through the immunoprecipitation
(IP). The knock out or knock down of mfn2 in the osteosarcoma cell through the
CRISPR/cas9 are vital important to our mechanism analysis. After the above clin-
ical research and cell based experiments, we would like to construct an mfn2
knock in mouse model and induce the development of osteosarcoma. We will study
the effect of mfn2 on the development and the progression of osteosarcoma and
the potential mechanism, to provide a research foundation for precision
treatment.
Results: (1) The expression of mfn2 is lower in osteosarcoma tissue than the adja-
cent non tumor tissue both in mRNA and protein level. And the low expression of
mfn2 is corrected with the poor prognosis. (2) We are the first time identified the
plk1 has an interaction with mfn2 through mass spectrometry analysis. The inter-
action between mfn2 and plk1 has been further confirmed through the IP. (3) The
stable line U2OS in which the mfn2 is knocked down has been obtained by the
CRISPR-cas9 technique. (4) There has a negative relationship between the expres-
sion level of mfn2 and plk1.
Conclusion: mfn2 is a novel tumors pressor for osteosarcoma. And it functions its




RESVERATROL ATTENUATES OXIDATIVE STRESS INDUCED UP-REGULATION OF
P-SELECTIN, PSGL-1, vWF AND TM VIA SIRT1 PATHWAY IN HUMAN UMBILICAL
VEIN ENDOTHELIAL CELLS
Zhenkai Lou
First Affiliated Hospital of Kunming Medical University, China
Objective: To investigate the effects and underlying mechanisms of resveratrol on
pro-thrombosis factors in human umbilical vein endothelial cells under oxidative
stress injury.
Methods: Construct H2O2 induced HUVEC cells injury model in vitro, inspecting PI3-
K/Akt/GSK3b, MAPKs, NF-kB and Nfr2/ARE signaling pathway in OSI mediated
endothelial cells injury and apoptosis, exploring effects and molecular mechanism
of resveratrol protecting venous endothelial cells from oxidative injury and
apoptosis. By overexpression and inhibition of SIRT1, explore regulation effects
of resveratrol on the secretions of pro-thrombotic moleculardP-Selectin, P-selec-
tin glycoprotein ligand-1 (PSGL-1), thrombomodulin (TM) and von Willebrand fac-
tor (vWF) in HUVECs and downstream key signaling pathways.Results: PI3-K/Akt/GSK3b, MAPKs (c-Jun, ERK1/2, p38), NF-kB, Nfr2/ARE signaling
pathway are involved in venous endothelial cells apoptosis induced by oxidative
stress. Resveratrol could inhibit pro-apoptotic pathway (MAPKs), inhibit inflamma-
tory response pathway (NF kappaB), up-regulate anti-apoptotic pathway (PI3-K/
Akt/GSK3b), protecting endothelial cells from oxidative stress induced apoptosis
and injury. Resveratrol could inhibit P-Selectin, PSGL-1, vWF and mRNA TM and
protein expression in oxidative induced endothelial cells via SIRT1 pathway.
Conclusion: Resveratrol could protect endothelial cells from oxidative induced
apoptosis and injury, inhibit pro-thrombosis molecules secretion, suggesting a
new target for drug prevention and treatment of deep venous thrombosis.
http://dx.doi.org/10.1016/j.jot.2016.06.207Session: Traumatology e Fixation
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SINGLE LOCKING PLATE CONSTRUCTS ARE LESS SENSITIVE TO SCREW
REMOVAL THAN DUAL LOCKING PLATE CONSTRUCTS FOR MID-DIAPHYSEAL
FRACTURE FIXATION
Arvind Nana a, Victor Kosmopoulos a, Keith Fishbeck b
aUniversity of North Texas Health Science Center, Fort Worth, Texas, USA
bUniversity of North Texas, Denton, Texas, USA
Background: Single large-fragment plate constructs are currently the norm for in-
ternal fixation of mid-diaphyseal humerus fractures. In cases where anatomy limits
the size of the humerus available for fixation however, recent studies support the
use of a dual small fragment locking plate construct. This study aims to compare
the simulated performance of both a single locking plate and a dual-locking plate
construct with decreasing number of locking screws and with changes in screw fix-
ation location.
Subjects and Methods: Mid-diaphyseal humeral fracture fixation using a single
(Model S) and a dual (Model D) locking plate construct were simulated using the
finite element method, a numerical technique commonly used to computationally
approximate solutions for complex structural mechanics problems. Different con-
figurations were tested by removal of either one or two screws from the superior
half of the fixation construct and compared to a control having no screws removed.
Models are labelled based on the location of the screw removed with 1 denoting
the most superior screw and 4 denoting the inferior screw adjacent to the fracture
(e.g., S1 denotes removal of the most superior screw from the single plate model).
Results: Model D4 was the only construct to show an increase in stiffness as
compared to the original dual plate construct without any screws removed. For
the single-plate constructs, models S1-S3 all resulted in less than 2.5% stiffness re-
ductions as compared to the control. Noteworthy, three of the single plate con-
structs, having two screws removed (models S12, S13, and S23), showed less
than a 6% reduction in construct stiffness. In contrast, all of the dual-plate con-
structs with 2 screws removed showed high stiffness reductions (greater than 55%).
Discussion and Conclusion: Results support that screw number and/or location
and construct type (single vs dual) are important factors to consider in achieving
successful fixation. Based on the simulations performed, the single plate models
were found to be less sensitive to screw removal. A balance must be achieved be-
tween hardware (i.e., screws and plate) stresses and construct stiffness. Increased
hardware stress can lead to early failure while changes in construct stiffness may
affect the ability for bone to heal. Future experimental and clinical studies are
needed for surgical recommendations especially with regards to the relationship
between our outcome measures and healing based on interfragmentary motion.
http://dx.doi.org/10.1016/j.jot.2016.06.208Session: Biomaterials and Implants e Bioinert/Bioactive Materials
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IN VITRO AND IN VIVO EVALUATION OF MACRO-PORE BIOGLASS BONE BLOCKS
AND THE APPLICATION IN LOAD-BEARING DEFECTIVE BONE
Xiaojie Li, Tenglong Hu, Liu Yang, Qiang Jie
Xijing Hospital, The Fourth Military Medical University, China
Seeking for a kind of suitable bone biomaterials to repair the heavy defective bone
of load-bearing region is an essential mission and effort direction of materials
experts and Orthopaedics Surgeons. Current biomaterials used in load-bearing
region are limited because of poor bioactivity. Therefore the generation of
bioactive bone substitute with improved mechanical features is a possible way
to dissolve these clinical problems. We develop a new bioactive bone substitute,
Macro- Pore Bone Block (MPBB), which presents good biomechanical strength and
persisting bioactivity. We implanted it into the femoral condyles of rabbits and
also, cultured osteoblasts on the surface of the material in vitro. The MPBB pre-
sents better mechanical strength and shows a good bioactivity and appropriate
degradation rate in the in vivo study. MPBB is also proved to promote osteoblast
adhesion, proliferation and differentiation in vitro. Furthermore, even a clinical
Poster Presentation Abstracts 137case application of the customized MPBB in pelvic Pemberton osteotomy shows a
sufficient compressive strength and wonderful biological activity which demon-
strates the good clinical effect. As such, this novel Bioglass-based graft material
might be a novel alternative in the reconstructions of hard tissue, especially for
use in application that require high load bearing implant materials.
http://dx.doi.org/10.1016/j.jot.2016.06.209Session: Disease & Treatment e Osteoporosis
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SCREENING OF OSTEOPOROSIS-RELATED PROTEIN MARKERS IN SERUM
Yaqian Hu, Zhuojie Zhao, Zhuojing Luo, Liu Yang
Xijing Hospital, The Fourth Military Medical University, China
Objective: Screening the serum markers which can reflect the development of
early stage of postmenopausal osteoporosis through protein ship.
Methods: Twenty 3-month-old female SD rats were randomly divided into sham
operation control group (Sham) and ovariectomy group (OVX), nZ10. The bone
mineral density (BMD) of distal femur and dynamic parameters of cancellous
bone morphology of the two groups rats were measured by micro CT at the end
of 2,4,6,8 weeks after operation. The blood of the two groups’ rats was taken
from angular vein at the same time. Using protein microarray to detect the con-
centration of 27 protein factors.
Results: Micro-CT examination showed that the BMD, BV/TV, Tb.Th, Tb.Sp of OVX
group rats began to decrease and Tb.N began to increase at the end of 4 weeks,
however there were no obvious changes in Sham group; there was significant dif-
ference between OVX and Sham groups by eighth weeks(P<0.05). Through the
detection of protein chip we found that IFNg of OVX group increased at 4th weeks
and b-NGF increased at 6th weeks after operation, there was significant difference
between OVX and Sham groups by eighth weeks (P<0.05).
Conclusion: The concentrations of IFNg and b-NGF began to increase at the early
stage of postmenopausal osteoporosis. Both of them are likely to be used as new
type of molecular markers in the diagnosis of the early stage of postmenopausal
osteoporosis.
http://dx.doi.org/10.1016/j.jot.2016.06.210Session: Disease & Treatment e Osteoporosis
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TETRAMETHYLPYRAZINE PROTECTS AGAINST APOPTOSIS THROUGH
PROMOTING AUTOPHAGY IN MESENCHYMAL STEM CELLS AND IMPROVES BONE
MASS IN GLUCOCORTICOID-INDUCED OSTEOPOROSIS RATS
Long Wang, Hongyang Zhang, Liu Yang, Zhuojing Luo
Xijing Hospital, The Fourth Military Medical University, China
Background: Glucocorticoids are widely used in clinic and have various adverse ef-
fects on bone cells leading to glucocorticoid-induced osteoporosis (GIOP). Excess
glucocorticoids could induce apoptosis of bone marrow-derived mesenchymal
stem cells (BMSCs) which play an important role in bone formation and skeletal ho-
meostasis. Tetramethylpyrazine (TMP), extracted from Chuanxiong which is one of
the most recognized traditional medicine, has been reported to have the anti-
apoptosis property.
Subjects and Methods: Here we tested whether TMP had a protective effect on
BMSCs under glucocorticoids exposure in vivo and in vitro. Fifty 4-month-old fe-
male Sprague-Dawley rats weighing 22318.5 g were obtained. Ten of them
were used to isolate BMSCs. We treated BMSCs with different concentrations of
TMP (50, 100, 200 mM) and exposed them to 106 M dexamethasone (Dex) for
48 h in vitro. The Cell Counting Kit-8 was used to measure cell viability. Cell
apoptosis was assessed by Annexin V/PI double staining and TUNEL staining.Transmission electron microscopy and western blot analysis were used to detect
the level of autophagy. Forty female SD rats were administered intraperitoneally
with either distilled water as the control group (nZ10) or 5 mg/kg prednisolone
as the GIOP group (nZ30) daily for 12 weeks. One week after the first administra-
tion, the 30 rats of the GIOP group were randomly divided into three experimental
groups of ten rats per group. The rats were injected intraperitoneally respectively
with sesame oil (as a vehicle control), 5 mg/kg or 20 mg/kg body weight of TMP
daily for 12 weeks. Calcein double labeling and micro-CT scanning were used to
monitor bone mass.
Results: Our data showed that TMP inhibited Dex-induced cytotoxicity and pro-
tected BMSCs from apoptosis. Interestingly, further results demonstrated that
TMP alleviated BMSCs apoptosis by promoting autophagy via AMPK/mTOR pathway.
In addition, calcein double labeling and micro-CT scanning indicated that 12 weeks
of TMP administration augmented bone formation and protected the trabecular
bone mass in GIOP rats. We also discovered that the first passage BMSCs isolated
from TMP treatment group showed lower apoptosis rate than GIOP group.
Discussion and Conclusion: Excess glucocorticoids are responsible for the
negative effects on BMSCs survival and function, and the defective BMSCs
would result in a reduction of osteogenesis and bone formation, and finally
contribute to bone loss in GIOP. For the first time we found that TMP could pro-
long BMSCs survival under excess glucocorticoids exposure by preserve viability
and inhibit apoptosis via promoting autophagy dependent on AMPK/mTOR
pathway in vitro. In vivo TMP administration increased bone formation and pre-
vented bone mass decrease in GIOP rats, and the protection on BMSCs against
apoptosis offered by TMP in GIOP state may be responsible for its anti-osteopo-
rosis effects. In conclusion, our findings suggested that TMP treatment and




BLOCKING HYPOXIA-INDUCED CXCR4 BY AMD3100 INHIBITS PRODUCTION OF
OA ASSOCIATED CATABOLIC MEDIATORS IL-1b AND MMP-13
Pengcui Li a, Lei Wei a,b, Xiaochun Wei a
aDepartment of Orthopaedics, The Second Hospital of Shanxi Medical University,
China
bDepartment of Orthopaedics, Warren Alpert Medical School of Brown University,
China
Binding of the chemokine SDF-1 to its receptor CXCR4 results in receptor activation
and the subsequent release of matrix metalloproteinases that contribute to
osteoarthritis cartilage degradation. As hypoxia is a defining feature of the
chondrocyte microenvironment, the present study investigated the possible
mechanism through which SDF-1 induces cartilage degradation under hypoxic
conditions. To do this, osteoarthritis chondrocyte cultures and patient tissue
explants that pretreated with the CXCR4 inhibitor AMD3100, were treated with
SDF-1. We discovered that hypoxic conditions significantly elevated the expression
of CXCR4 in osteoarthritic chondrocytes relative to normoxic conditions. Further-
more, SDF-1 elevated MMP-13 mRNA levels and proteinase activity. It also elevated
the mRNA and protein levels of Runx2, and induced the release of glycosamino-
glycans and the inflammatory cytokine IL-1b. In contrast, such changes did not
occur to an appreciable degree in cells that were pretreated with AMD3100. Our
results demonstrate that even under hypoxic conditions where CXCR4 is signifi-
cantly elevated by chondrocytes, AMD3100 effectively blocks this receptor and
protects chondrocytes from osteoarthritis induced catabolism, suggesting that the
successful inhibition of CXCR4 may be an effective approach towards osteoarthritis
treatment.
http://dx.doi.org/10.1016/j.jot.2016.06.212
